| Michelle Charbonnet Steinhardt, MD | |
|
500 Rue De La Vie, Suite 405, Baton Rouge, LA 70817-5128 | |
| (225) 928-2555 | |
| (225) 929-9685 |
| Full Name | Michelle Charbonnet Steinhardt |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 500 Rue De La Vie, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487953287 | NPI | - | NPPES |
| 2151487 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | MD.207153 (Louisiana) | Primary |
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
Health law backers question the predictions of insurance "rate shock," because they are made by actuaries who have close ties to the industry.
One in two women in the United States will have an osteoporosis-related fracture in her lifetime. However, according to a review article published in the May 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), only a few of these women will be tested and treated for osteoporosis, which if identified and treated, could dramatically decrease their risk of future fractures.
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 7 days ago
| Entity Name | Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043230873 PECOS PAC ID: 3971401944 Enrollment ID: O20031229000715 |
News Archive
Health law backers question the predictions of insurance "rate shock," because they are made by actuaries who have close ties to the industry.
One in two women in the United States will have an osteoporosis-related fracture in her lifetime. However, according to a review article published in the May 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), only a few of these women will be tested and treated for osteoporosis, which if identified and treated, could dramatically decrease their risk of future fractures.
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 7 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245434224 PECOS PAC ID: 0446163760 Enrollment ID: O20040114000146 |
News Archive
Health law backers question the predictions of insurance "rate shock," because they are made by actuaries who have close ties to the industry.
One in two women in the United States will have an osteoporosis-related fracture in her lifetime. However, according to a review article published in the May 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), only a few of these women will be tested and treated for osteoporosis, which if identified and treated, could dramatically decrease their risk of future fractures.
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 7 days ago
| Entity Name | Childrens Hospital Medical Practice Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821090713 PECOS PAC ID: 5597944579 Enrollment ID: O20110124000073 |
News Archive
Health law backers question the predictions of insurance "rate shock," because they are made by actuaries who have close ties to the industry.
One in two women in the United States will have an osteoporosis-related fracture in her lifetime. However, according to a review article published in the May 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), only a few of these women will be tested and treated for osteoporosis, which if identified and treated, could dramatically decrease their risk of future fractures.
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Charbonnet Steinhardt, MD P O Box 45171, Baton Rouge, LA 70895-4171 Ph: (225) 928-2555 | Michelle Charbonnet Steinhardt, MD 500 Rue De La Vie, Suite 405, Baton Rouge, LA 70817-5128 Ph: (225) 928-2555 |
News Archive
Health law backers question the predictions of insurance "rate shock," because they are made by actuaries who have close ties to the industry.
One in two women in the United States will have an osteoporosis-related fracture in her lifetime. However, according to a review article published in the May 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), only a few of these women will be tested and treated for osteoporosis, which if identified and treated, could dramatically decrease their risk of future fractures.
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 7 days ago
Manish Gope Raisingani, Pediatrics Medicare: Medicare Enrolled Practice Location: 8200 Constantin Blvd Fl 4, Baton Rouge, LA 70809 Phone: 225-765-5500 Fax: 225-765-1733 | |
Dr. Daniel Gregg Sloven, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8200 Constantin Blvd Fl 4, Baton Rouge, LA 70809 Phone: 225-765-5500 Fax: 225-765-2054 | |
Traci T. Lacy, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Dr. Michelle L Flechas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12525 Perkins Rd, Suite C, Baton Rouge, LA 70810 Phone: 225-769-2003 Fax: 225-767-3055 | |
Dr. Richard Francis Lasseigne Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8300 Constantin Blvd, Baton Rouge, LA 70809 Phone: 225-374-1410 Fax: 225-374-1616 | |
Dr. Horace Jay Collinsworth, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8415 Goodwood Blvd, Suite 100, Baton Rouge, LA 70806 Phone: 225-765-5633 Fax: 225-765-5634 | |
Myriam Aracelis Ortiz-de Jesus', MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11424 Sullivan Rd, Suite B1, Baton Rouge, LA 70818 Phone: 225-761-5200 |